[YTL] QoQ Cumulative Quarter Result on 30-Sep-2008 [#1]

Stock
[YTL] YTL CORPORATION BHD
Announcement Date
20-Nov-2008
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2009
Quarter
30-Sep-2008 [#1]
Profit Trend
QoQ- -67.22%
YoY- 12.36%
Quarter Report
Latest QR
Upcoming QR
YTL's Result
YTL's Financial Summary
View:
Show?
Cumulative Result
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Revenue 8,892,125 5,348,974 3,363,829 1,739,212 6,549,860 4,731,695 3,098,029 102.09%
PBT 2,288,197 1,604,439 854,435 569,747 1,829,842 1,403,458 918,945 83.81%
Tax -886,582 -317,156 -193,061 -101,380 -453,355 -328,629 -230,576 145.63%
NP 1,401,615 1,287,283 661,374 468,367 1,376,487 1,074,829 688,369 60.71%
-
NP to SH 834,472 787,150 302,789 252,367 769,786 616,462 413,935 59.65%
-
Tax Rate 38.75% 19.77% 22.60% 17.79% 24.78% 23.42% 25.09% -
Total Cost 7,490,510 4,061,691 2,702,455 1,270,845 5,173,373 3,656,866 2,409,660 113.14%
-
Net Worth 8,322,805 7,974,078 7,321,865 7,712,144 8,254,698 7,323,340 7,502,778 7.16%
Dividend
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Div 116,240 - - - 373,888 337,972 225,209 -35.68%
Div Payout % 13.93% - - - 48.57% 54.82% 54.41% -
Equity
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Net Worth 8,322,805 7,974,078 7,321,865 7,712,144 8,254,698 7,323,340 7,502,778 7.16%
NOSH 1,549,870 1,521,945 1,504,915 1,495,065 1,495,552 1,502,100 1,501,396 2.14%
Ratio Analysis
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
NP Margin 15.76% 24.07% 19.66% 26.93% 21.02% 22.72% 22.22% -
ROE 10.03% 9.87% 4.14% 3.27% 9.33% 8.42% 5.52% -
Per Share
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
RPS 573.73 351.46 223.52 116.33 437.96 315.01 206.34 97.85%
EPS 54.10 51.72 20.12 16.88 51.54 41.04 27.57 56.80%
DPS 7.50 0.00 0.00 0.00 25.00 22.50 15.00 -37.03%
NAPS 5.37 5.2394 4.8653 5.1584 5.5195 4.8754 4.9972 4.91%
Adjusted Per Share Value based on latest NOSH - 1,495,065
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
RPS 80.14 48.21 30.32 15.68 59.03 42.65 27.92 102.10%
EPS 7.52 7.09 2.73 2.27 6.94 5.56 3.73 59.65%
DPS 1.05 0.00 0.00 0.00 3.37 3.05 2.03 -35.58%
NAPS 0.7501 0.7187 0.6599 0.6951 0.744 0.66 0.6762 7.16%
Price Multiplier on Financial Quarter End Date
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Date 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 -
Price 1.30 1.30 1.32 1.17 1.27 1.39 1.48 -
P/RPS 0.23 0.37 0.59 1.01 0.29 0.44 0.72 -53.30%
P/EPS 2.41 2.51 6.56 6.93 2.47 3.39 5.37 -41.41%
EY 41.42 39.78 15.24 14.43 40.53 29.53 18.63 70.42%
DY 5.77 0.00 0.00 0.00 19.69 16.19 10.14 -31.35%
P/NAPS 0.24 0.25 0.27 0.23 0.23 0.29 0.30 -13.83%
Price Multiplier on Announcement Date
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Date 20/08/09 21/05/09 19/02/09 20/11/08 19/08/08 22/05/08 22/02/08 -
Price 1.34 1.32 1.34 1.19 1.14 1.40 1.44 -
P/RPS 0.23 0.38 0.60 1.02 0.26 0.44 0.70 -52.41%
P/EPS 2.49 2.55 6.66 7.05 2.21 3.41 5.22 -38.97%
EY 40.18 39.18 15.01 14.18 45.15 29.31 19.15 63.96%
DY 5.60 0.00 0.00 0.00 21.93 16.07 10.42 -33.92%
P/NAPS 0.25 0.25 0.28 0.23 0.21 0.29 0.29 -9.42%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment